Amylyx CCO Margaret Olinger to depart Dec 31, 2023; search underway

Amylyx Pharmaceuticals, Inc.

Margaret Olinger, Chief Commercial Officer, will leave Amylyx effective end of day Dec 31, 2023.
Company has initiated a search for a new Chief Commercial Officer.
Olinger's departure is not related to any disagreement with Amylyx regarding operations, policies, or practices.

item 7.01

Amylyx Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-290302

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.